Health Eli Lilly’s obesity pill outperforms Novo Nordisk’s oral drug in head-to-head diabetes trialHealthradar17. September 2025 submitted by /u/cnbc_official [comments] Source link
Health Eli Lilly’s obesity pill remains a viable rival to Novo’s oral Wegovy despite data that underwhelmed investorsHealthradar25. August 2025 submitted by /u/cnbc_official [comments] Source link
Health Lilly’s New Oral GLP-1 Orforglipron Led to 12% Weight Loss in TrialsHealthradar14. August 2025 Share on PinterestGLP-1 drugmaker Eli Lilly’s new weight loss pill orforglipron showed meaningful weight loss results in a recent clinical…
